Medical Research News

RSS

Researchers trace soaring poison control calls to semaglutide approval for weight loss

When semaglutide's popularity exploded following FDA approval for weight management in 2021, so too did a wave of calls to poison control centers.

23 Jun 2026

Scientists discover how food poisoning bacteria protect themselves from antibiotics

Scientists from the Department of Microbiology of the University of Malaga, also members of the Institute of Subtropical and Mediterranean Horticulture 'La Mayora' (IHSM), have discovered a hitherto unknown mechanism that allows the bacterium Bacillus cereus, which is responsible for food poisoning and human infections, to protect itself against antibiotics and adverse conditions.

23 Jun 2026

Researchers identify control switch protein that starves tuberculosis bacteria

A protein that acts as a 'control switch,' preventing Mycobacterium tuberculosis from accessing the energy sources it needs to survive, has been identified by researchers at the University of Surrey.

23 Jun 2026

Synthetic protein hybrid offers promising treatment for liver diseases

The research group led by CIC biomaGUNE's Ikerbasque Research Professor Aitziber L. Cortajarena has developed an innovative anti-fibrotic and anti-tumor treatment by binding a synthetic protein to gold nanoclusters (small aggregates of approximately 6 atoms of gold).

23 Jun 2026

New project aims to systematically map billion cellular interactions

...

23 Jun 2026

Curtin University projects explore youth health issues in Western Australia

Curtin University Curtin University researchers will examine the 'partygoing' behaviours of young people in regional areas, the use of nicotine pouches and ways to promote physical activity among young people as part of new projects funded by Healthway.

23 Jun 2026

TRIMTECH Therapeutics brings total seed round to $47 M with additional investment of $14 M to further develop TRIMTAC and TRIMGLUE targeted protein degradation portfolio

TRIMTECH Therapeutics, a biotechnology company developing novel small molecule therapies that target and degrade protein aggregates associated with neurodegenerative diseases, today announced it has raised an additional $14 million in seed funding, bringing the total for the round to $47 million (£35 million).

From TRIMTECH Therapeutics 23 Jun 2026

The menstrual cycle changes heart-rate variability but not strength

Menstrual cycle phases influence heart autonomic regulation, showing HRV variations, yet muscle performance and mood states remain largely unchanged.

23 Jun 2026

Elite athletes with higher vitamin D show healthier lipid profiles

Higher serum 25-hydroxyvitamin D levels were independently associated with lower LDL-C, triglycerides, and lipoprotein(a) in 773 male professional athletes. The cross-sectional study cannot establish causality, but it suggests that vitamin D status may be linked to cardiovascular risk-related lipid markers, even in elite athletic populations.

23 Jun 2026

Trial identifies 4 grams a day as the tested safe level for L-tyrosine in healthy men

A randomized, crossover trial in healthy adult men found that 4 weeks of L-tyrosine supplementation at doses up to 4 g/day did not cause clinically meaningful changes in safety markers, diet, blood pressure, or body measures. The highest tested dose, 4 g/day, was identified as the no-observed-adverse-effect level under the study’s four-week conditions, although broader and longer-term studies are still needed.

23 Jun 2026

50-year review shows global Ebola spread remains rare despite outbreak fears

Researchers reviewed Ebola disease cases outside Africa from 1976 to May 2026 and found only 28 confirmed epidemic-linked cases, most involving medical evacuation or occupational exposure. Only four latent travelers were diagnosed after border screening, suggesting that undetected intercontinental spread remains rare when outbreaks are controlled at source.

23 Jun 2026

Andes virus cases on MV Hondius highlight hidden risks of confined travel

A Eurosurveillance report describes a multi-country response to an Andes virus outbreak linked to the Dutch-flagged expedition cruise ship MV Hondius, with 13 cases and three deaths reported as of June 18, 2026. Investigators found evidence consistent with an initial zoonotic infection before embarkation, followed by likely person-to-person transmission among passengers and crew in a confined ship setting.

23 Jun 2026

Accelerated biological aging may drive rising early-onset cancer risk

Cancer is often considered a disease of aging. Older adults are at higher risk because they have had more time to accumulate cellular damage that can trigger tumor formation.

22 Jun 2026

Hyperemesis gravidarum increases risks for pregnancy and birth complications

Pregnant women with a severe form of nausea face increased risks for several pregnancy and birth complications, according to a new Stanford Medicine study of 2.5 million California births.

22 Jun 2026

Novel IL1RAP therapy advances toward pancreatic cancer clinical trial

Blocking IL1RAP, a receptor that sits at a key control point in inflammatory signaling, can disrupt the tumor-driven inflammatory network that helps pancreatic cancer resist treatment, according to new research.

22 Jun 2026

Psychological traits may uncover why Alzheimer’s biology differs between patients

In 822 deceased older adults from ROS and MAP, researchers linked stable psychological traits to multi-omic molecular subtypes of Alzheimer’s dementia using postmortem brain tissue from the dorsolateral prefrontal cortex. Neuroticism and loneliness were associated with molecular progression, while purpose in life showed subtype-specific inverse associations, suggesting psychological traits may align with Alzheimer’s biology beyond conventional neuropathology.

22 Jun 2026

Amazon land use patterns reveal where vector-borne diseases collide

Researchers found that malaria-Chagas and dengue-ATL hotspots in the Brazilian Amazon aligned with distinct agrarian, socioeconomic, and environmental landscapes. The findings suggest that disease surveillance should account for land use, poverty, forest structure, mining, and local livelihoods rather than treating each infection in isolation.

22 Jun 2026

Statins may trigger muscle side effects by activating inflammatory danger signals

An experimental study in Science Advances shows that statins, primarily fluvastatin in these experiments, may promote low-level muscle myopathy by reducing isoprenoid-dependent protein prenylation rather than by cholesterol lowering. In primed muscle cells and mouse models, impaired YAP signaling, reduced glycolysis, NLRP3/caspase-1 activation, and nuclear FOXO accumulation increased atrogin-1, reduced protein synthesis, and weakened muscle function.

22 Jun 2026

Scientists trace cardiac aging to a fading regulator in heart muscle cells

Researchers mapped 442,239 single nuclei from nonfailing human hearts to chart how cardiac cells change from fetal development to older adulthood. The study identified PRDM16 as an age-declining cardiomyocyte regulator, with experimental evidence showing that restoring Prdm16 in aged mouse hearts improved systolic function and partly reversed aging-associated transcriptional patterns.

22 Jun 2026